uniQure Ownership | Who Owns uniQure?

Overview Forecast RevenueFinancials Chart

uniQure Ownership Summary

uniQure is owned by 79.21% institutional investors, 8.69% insiders, and 12.10% retail investors. Ecor1 capital is the largest institutional shareholder, holding 6.98% of QURE shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 2.32% of its assets in uniQure shares.

QURE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	uniQure	79.21%	8.69%	12.10%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ecor1 capital	3.40M	6.98%	$60.04M
Vestal point capital, lp	3.02M	6.21%	$53.42M
Nantahala capital management	2.45M	5.04%	$43.33M
Avoro capital advisors	2.17M	4.46%	$38.41M
Franklin resources	1.99M	4.08%	$35.10M
Blackrock	1.93M	3.98%	$8.63M
Point72 asset management	1.77M	3.64%	$31.28M
683 capital management	1.52M	3.13%	$26.93M
Abrdn	1.51M	3.10%	$26.65M
Blackrock funding, inc. /de	1.42M	2.91%	$25.00M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Vestal point capital, lp	3.02M	3.17%	$53.42M
Pale fire capital se	580.71K	2.33%	$10.26M
Ecor1 capital	3.40M	2.27%	$60.04M
Nantahala capital management	2.45M	1.86%	$43.33M
683 capital management	1.52M	1.67%	$26.93M
Sectoral asset management	71.50K	0.84%	$1.26M
Privium fund management b.v.	640.42K	0.66%	$2.57M
Parkman healthcare partners	275.00K	0.65%	$4.86M
Avoro capital advisors	2.17M	0.54%	$38.41M
Sonic gp	50.00K	0.46%	$224.00K

Top Buyers

Holder	Shares	% Assets	Change
Ecor1 capital	3.40M	2.27%	3.40M
Avoro capital advisors	2.17M	0.54%	2.17M
Point72 asset management	1.77M	0.07%	794.46K
Fmr	966.65K	0.00%	616.08K
Schonfeld strategic advisors	536.42K	0.06%	536.42K

Top Sellers

Holder	Shares	% Assets	Change
Millennium management	464.54K	0.00%	-1.73M
Vestal point capital, lp	3.02M	3.17%	-1.73M
Schroder investment management group	834.08K	0.01%	-634.57K
Ikarian capital	-	-	-469.13K
Hudson bay capital management lp	175.00K	0.01%	-460.50K

New Positions

Holder	Shares	% Assets	Change	Value
Ecor1 capital	3.40M	2.27%	3.40M	$60.04M
Avoro capital advisors	2.17M	0.54%	2.17M	$38.41M
Lord, abbett	314.41K	0.02%	314.41K	$5.55M
Parkman healthcare partners	275.00K	0.65%	275.00K	$4.86M
Norges bank	207.10K	0.00%	207.10K	$927.81K

Sold Out

Holder	Change
Northwestern mutual wealth management	-1.00
Nelson, van denburg & campbell wealth management group	-32.00
Financial gravity asset management	-49.00
Visionpoint advisory group	-66.00
Ifp advisors	-100.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	148	4.23%	38,592,241	-0.74%	79	1.24%	68	-2.86%	45	21.62%
Sep 30, 2024	141	9.30%	38,878,066	22.43%	79	1.85%	69	23.21%	37	-
Jun 30, 2024	129	-6.52%	31,756,298	-1.57%	65	1.44%	56	-22.22%	37	15.63%
Mar 31, 2024	138	-11.54%	32,262,781	-13.94%	67	1.10%	72	-	32	-43.86%
Dec 31, 2023	156	-10.86%	37,489,885	3.53%	78	1.36%	72	-22.58%	57	29.55%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Franklin Biotechnology Discv A(acc)USD	1.25M	2.32%	-
International Biotechnology Ord	1.19M	2.23%	116.45K
abrdn Healthcare Investors	1.15M	2.15%	181.84K
SPDR® S&P Biotech ETF	1.01M	1.87%	-10.85K
Delaware Healthcare I	706.17K	1.45%	-
Franklin Biotechnology Discovery A	733.50K	1.36%	-
Macquarie Healthcare I	706.17K	1.31%	-
Vanguard Institutional Extnd Mkt Idx Tr	700.14K	1.29%	1.11K
abrdn Life Sciences Investors	542.25K	1.01%	76.62K
AlphaCentric Life Sciences & Hlthcare I	460.00K	0.94%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 04, 2025	Kapusta Matthew C	CEO, Managing Director	Sell	$291.63K
Mar 04, 2025	Abi-Saab Walid	Chief Medical Officer	Sell	$13.89K
Mar 04, 2025	KLEMT CHRISTIAN	Chief Financial Officer	Sell	$107.41K
Mar 04, 2025	Potts Jeannette	Chief Legal Officer	Sell	$72.81K
Feb 25, 2025	Kapusta Matthew C	CEO, Managing Director	Sell	$285.98K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	8
2024 Q4	-	3
2024 Q2	-	12
2024 Q1	-	3
2023 Q4	-	-

QURE Ownership FAQ

Who Owns uniQure?

uniQure shareholders are primarily institutional investors at 79.21%, followed by 8.69% insiders and 12.10% retail investors. The average institutional ownership in uniQure's industry, Biotech Stocks , is 68.48%, which uniQure exceeds.

Who owns the most shares of uniQure?

uniQure’s largest shareholders are Ecor1 capital (3.4M shares, 6.98%), Vestal point capital, lp (3.02M shares, 6.21%), and Nantahala capital management (2.45M shares, 5.04%). Together, they hold 18.22% of uniQure’s total shares outstanding.

Does Blackrock own uniQure?

Yes, BlackRock owns 3.98% of uniQure, totaling 1.93M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.63M$. In the last quarter, BlackRock increased its holdings by 65.08K shares, a 3.50% change.

Who is uniQure’s biggest shareholder by percentage of total assets invested?

Vestal point capital, lp is uniQure’s biggest shareholder by percentage of total assets invested, with 3.17% of its assets in 3.02M uniQure shares, valued at 53.42M$.

Who is the top mutual fund holder of uniQure shares?

Franklin Biotechnology Discv A(acc)USD is the top mutual fund holder of uniQure shares, with 2.32% of its total shares outstanding invested in 1.25M uniQure shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools